EP1513559A4 - Delivrance augmentee d un produit de recombinaison d acide nucleique in vivo par le systeme poly-l-glutamate (plg) - Google Patents

Delivrance augmentee d un produit de recombinaison d acide nucleique in vivo par le systeme poly-l-glutamate (plg)

Info

Publication number
EP1513559A4
EP1513559A4 EP03741818A EP03741818A EP1513559A4 EP 1513559 A4 EP1513559 A4 EP 1513559A4 EP 03741818 A EP03741818 A EP 03741818A EP 03741818 A EP03741818 A EP 03741818A EP 1513559 A4 EP1513559 A4 EP 1513559A4
Authority
EP
European Patent Office
Prior art keywords
constrtuct
plg
glutamate
vivo
poly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03741818A
Other languages
German (de)
English (en)
Other versions
EP1513559A1 (fr
Inventor
Ruxandra Draghia-Akli
Robert H Carpenter
Douglas R Kern
Leigh Anne Hill
Heather Attra
Henry Hebel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advisys Inc
Original Assignee
Advisys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/395,709 external-priority patent/US20040014645A1/en
Application filed by Advisys Inc filed Critical Advisys Inc
Publication of EP1513559A1 publication Critical patent/EP1513559A1/fr
Publication of EP1513559A4 publication Critical patent/EP1513559A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP03741818A 2002-05-28 2003-05-23 Delivrance augmentee d un produit de recombinaison d acide nucleique in vivo par le systeme poly-l-glutamate (plg) Withdrawn EP1513559A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15667002A 2002-05-28 2002-05-28
US156670 2002-05-28
US10/395,709 US20040014645A1 (en) 2002-05-28 2003-03-24 Increased delivery of a nucleic acid construct in vivo by the poly-L-glutamate ("PLG") system
US395709 2003-03-24
PCT/US2003/016541 WO2003099341A1 (fr) 2002-05-28 2003-05-23 Delivrance augmentee d'un produit de recombinaison d'acide nucleique in vivo par le systeme poly-l-glutamate (plg)

Publications (2)

Publication Number Publication Date
EP1513559A1 EP1513559A1 (fr) 2005-03-16
EP1513559A4 true EP1513559A4 (fr) 2006-01-18

Family

ID=29586320

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03741818A Withdrawn EP1513559A4 (fr) 2002-05-28 2003-05-23 Delivrance augmentee d un produit de recombinaison d acide nucleique in vivo par le systeme poly-l-glutamate (plg)

Country Status (7)

Country Link
EP (1) EP1513559A4 (fr)
CN (1) CN1662261A (fr)
AU (1) AU2003273142A1 (fr)
BR (1) BR0311539A (fr)
CA (1) CA2485976A1 (fr)
MX (1) MXPA04011766A (fr)
WO (1) WO2003099341A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005089810A1 (ja) * 2004-03-22 2008-01-31 関西ティー・エル・オー株式会社 エレクトロポレーション法を用いたヒト骨形成因子遺伝子導入による骨誘導方法
US20060025368A1 (en) * 2004-07-23 2006-02-02 Advisys, Inc. Growth hormone releasing hormone enhances vaccination response

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001006988A2 (fr) * 1999-07-26 2001-02-01 Baylor College Of Medicine Analogue superactif de la somatostatine porcine
WO2001066149A2 (fr) * 2000-03-03 2001-09-13 Valentis, Inc. Formulations d'acide nucleique pour transfert de genes et procedes d'utilisation
WO2003049700A2 (fr) * 2001-12-11 2003-06-19 Advisys, Inc. Supplementation induite par les plasmides dans le traitement de maladies chroniques affectant des sujets

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001006988A2 (fr) * 1999-07-26 2001-02-01 Baylor College Of Medicine Analogue superactif de la somatostatine porcine
WO2001066149A2 (fr) * 2000-03-03 2001-09-13 Valentis, Inc. Formulations d'acide nucleique pour transfert de genes et procedes d'utilisation
WO2003049700A2 (fr) * 2001-12-11 2003-06-19 Advisys, Inc. Supplementation induite par les plasmides dans le traitement de maladies chroniques affectant des sujets

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DRAGHIA-AKLI R ET AL: "ELECTRICAL ENHANCEMENT OF FORMULATED PLASMID DELIVERY IN ANIMALS", TECHNOLOGY IN CANCER RESEARCH AND TREATMENT, ADENINE PRESS, SCHENECTADY, NY, US, vol. 1, no. 5, October 2002 (2002-10-01), pages 365 - 371, XP001182428, ISSN: 1533-0346 *
FEWELL J G ET AL: "Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation", MOLECULAR THERAPY, ACADEMIC PRESS, SAN DIEGO, CA,, US, vol. 3, no. 4, April 2001 (2001-04-01), pages 574 - 583, XP002965532, ISSN: 1525-0016 *
See also references of WO03099341A1 *

Also Published As

Publication number Publication date
CA2485976A1 (fr) 2003-12-04
EP1513559A1 (fr) 2005-03-16
CN1662261A (zh) 2005-08-31
MXPA04011766A (es) 2005-03-31
AU2003273142A1 (en) 2003-12-12
BR0311539A (pt) 2005-10-25
WO2003099341A1 (fr) 2003-12-04

Similar Documents

Publication Publication Date Title
GB2391480B (en) Drug delivery system
AU2003290524A8 (en) Nanoparticle delivery system
SI1631255T1 (sl) Sistem za razdeljevanje zdravil
HUP0401438A3 (en) Drug delivery system
PL376169A1 (en) Drug delivery system
EP1540157A4 (fr) Systeme ameliore de fourniture de carburant
AU2002348163A1 (en) Therapeutic methods for nucleic acid delivery vehicles
GB0311959D0 (en) Energy delivery system
AP2006003602A0 (en) Oral drug delivery system
GB0106860D0 (en) Vehicle delivery system
GB0103877D0 (en) Novel Drug Delivery system
EG24425A (en) Drug delivery assembly
EP1543231A4 (fr) Systeme d'alimentation en carburant
EP1513559A4 (fr) Delivrance augmentee d un produit de recombinaison d acide nucleique in vivo par le systeme poly-l-glutamate (plg)
EP1509612A4 (fr) Systeme de distribution transcellulaire de medicaments
GB0110525D0 (en) Nucleic acid delivery
GB0112585D0 (en) Nucleic acid delivery
AU2003297107A8 (en) Sacromastigophoric therapeutic agent delivery system
GB2406518B (en) Agent delivery system
GB0327409D0 (en) Delivery system
TWI350189B (en) Implantable drug delivery system
GB0112326D0 (en) Drug delivery system
GB0115136D0 (en) Drug delivery system
GB0209411D0 (en) Drug delivery
GB0217478D0 (en) Multiple-therapy drug delivery

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20041222

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 14/60 B

Ipc: 7C 12N 15/63 B

Ipc: 7A 61K 48/00 A

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20051206

17Q First examination report despatched

Effective date: 20080519

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20101201